Table 2. Associations of c-Met expression with FNG, T-stage, and PD-L1 status, according to tumor site.

	c-Met expression in primary tumors			c-Met expression in metastatic tumors
Characteristic	N	Median (IQR)	p-value*	N	Median (IQR)	p-value*
FNG			0.04			0.42
III	32	20 (6,43)		32	53 (14,81)
IV	13	52 (20,75)		13	60 (35,130)
T-stage			0.13			0.72
Tx-T2	20	24 (9,38)		20	48 (26,81)
T3-T4	25	30 (12,70)		25	55 (30,83)
PD-L1 status			0.34			0.45
(-), ≤ 0%	32	24 (9,46)		36	51 (26,81)
(+), > 0%	13	30 (12,64)		9	60 (35,130)